MedElevator Войти в исследования
← Поиск публикаций

DOI 10.2807/1560-7917.es.2025.30.44.2500254

Медицинская библиотека · Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2025

Hepatitis E virus screening in solid organ transplant recipients: prevalence and implications for implementation, Spain, 2021 to 2023.

Pereira Sara, Pérez-Rivilla Alfredo, Carracedo Raquel, López-López Pedro, Rodríguez-Iglesias Manuel, Benito Rafael, Fuentes Ana, López-Ruz Miguel Ángel, Freyre-Carrillo Carolina, Del Valle Odero María, Parajó Noelia, García Federico, Rivero Antonio, Rivero-Juárez Antonio, Aguilera Antonio

СтатьяМногоцентровое исследованиеПеревод в очереди

Аннотация

INTRODUCTION

In solid organ transplant (SOT) recipients, hepatitis E virus (HEV) poses a complex clinical challenge, because there is a risk of developing persistent infection. Current European guidelines recommend the screening of HEV in SOT recipients because of the risk of unrecognised infection. Despite these recommendations, routine screening for HEV remains underutilised in clinical practice.

AIM: Our study aimed to determine the prevalence of HEV viraemia and to evaluate the clinical evolution of HEV infection in SOT.

METHODS

We performed a multicentre cross-sectional study including adult SOT recipients under follow-up in Spain. All patients were prospectively tested for HEV RNA in peripheral blood. Individuals with detectable viraemia were prospectively followed up every 3 months to evaluate viral persistence.

RESULTS

A total of 940 patients were included in the study. Five patients were infected, supposing a prevalence of HEV infection in Spanish SOT recipients of 0.53% (95% confidence interval: 0.23-1.24). Genotyping was successfully conducted in four cases, all identified as genotype 3. All patients were asymptomatic and had varied levels of liver enzyme elevations. At follow-up, three of the five patients remained HEC RNA-positive, consistent with chronic infection. Overall, the prevalence of chronic HEV infection in our study population was 0.32%.

CONCLUSION

Our study highlights the need to establish periodic molecular HEV surveillance in SOT recipients.

Для цитирования: Pereira Sara, Pérez-Rivilla Alfredo, Carracedo Raquel, López-López Pedro, Rodríguez-Iglesias Manuel, Benito Rafael, Fuentes Ana, López-Ruz Miguel Ángel, Freyre-Carrillo Carolina, Del Valle Odero María, Parajó Noelia, García Federico, Rivero Antonio, Rivero-Juárez Antonio, Aguilera Antonio. Hepatitis E virus screening in solid organ transplant recipients: prevalence and implications for implementation, Spain, 2021 to 2023.. Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin. 2025. DOI: 10.2807/1560-7917.es.2025.30.44.2500254.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.